Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.66)
# 732
Out of 4,784 analysts
81
Total ratings
37.97%
Success rate
10.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.57 | +951.71% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $8.46 | +467.38% | 1 | Feb 28, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $94 → $110 | $13.14 | +737.14% | 2 | Feb 26, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $36.50 | +154.79% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $6.87 | +991.70% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.74 | +848.12% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $8.28 | +214.01% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $23.27 | +119.17% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $21.76 | +70.04% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $1.27 | +1,955.34% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $20 | $2.60 | +669.23% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.20 | +2,233.33% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $34.73 | +179.30% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $38.66 | +598.40% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $18.65 | +307.51% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.32 | +369.92% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.43 | +123.38% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $4.21 | +185.04% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $62.70 | -42.58% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.61 | +1,365.80% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $17.44 | +932.11% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.17 | +1,182.05% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $327.87 | +2.48% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.91 | +449.83% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $18.95 | +322.16% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $71.99 | +29.18% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $19.77 | +370.41% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $16.65 | +290.39% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $18.37 | +210.29% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $3.71 | +1,705.93% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $48.88 | -28.40% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.23 | +9,461.06% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $5.71 | +1,423.64% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.12 | +1,818.86% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $43.19 | +66.71% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.47 | +1,736.73% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $8.08 | +135.15% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.21 | +4,032.23% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.64 | +6,126.65% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.42 | +4,173.50% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.44 | +4,670.56% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $11.58 | +564.94% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $45.99 | +67.43% | 1 | Jul 31, 2020 |
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.57
Upside: +951.71%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $8.46
Upside: +467.38%
Prothena Corporation
Feb 26, 2025
Maintains: Overweight
Price Target: $94 → $110
Current: $13.14
Upside: +737.14%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $36.50
Upside: +154.79%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $6.87
Upside: +991.70%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.74
Upside: +848.12%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $8.28
Upside: +214.01%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $23.27
Upside: +119.17%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $21.76
Upside: +70.04%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.27
Upside: +1,955.34%
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $2.60
Upside: +669.23%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.20
Upside: +2,233.33%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $34.73
Upside: +179.30%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $38.66
Upside: +598.40%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $18.65
Upside: +307.51%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.32
Upside: +369.92%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.43
Upside: +123.38%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $4.21
Upside: +185.04%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $62.70
Upside: -42.58%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.61
Upside: +1,365.80%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $17.44
Upside: +932.11%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.17
Upside: +1,182.05%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $327.87
Upside: +2.48%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.91
Upside: +449.83%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $18.95
Upside: +322.16%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $71.99
Upside: +29.18%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $19.77
Upside: +370.41%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $16.65
Upside: +290.39%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $18.37
Upside: +210.29%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $3.71
Upside: +1,705.93%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $48.88
Upside: -28.40%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.23
Upside: +9,461.06%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $5.71
Upside: +1,423.64%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.12
Upside: +1,818.86%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $43.19
Upside: +66.71%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.47
Upside: +1,736.73%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $8.08
Upside: +135.15%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.21
Upside: +4,032.23%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.64
Upside: +6,126.65%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.42
Upside: +4,173.50%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.44
Upside: +4,670.56%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $11.58
Upside: +564.94%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $45.99
Upside: +67.43%